NCT00278525View on ClinicalTrials.gov

Cyclophosphamide and rATG With Hematopoietic Stem Cell Support in Systemic Scleroderma

PHASE2CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

September 30, 2011

Study Completion Date

December 31, 2012

Conditions
SYSTEMIC SCLERODERMA
Interventions
DRUG

standard of care

standard of care medication will be given

PROCEDURE

stem cell transplantation

The following is intervention: stem cell transplantation after conditioning regimen

Trial Locations (1)

60611

Northwestern University, Feinberg School of Medicine, Chicago

All Listed Sponsors
lead

Northwestern University

OTHER

NCT00278525 - Cyclophosphamide and rATG With Hematopoietic Stem Cell Support in Systemic Scleroderma | Biotech Hunter | Biotech Hunter